Epithalon is strictly for laboratory research and is commonly employed in the following investigational areas:

Telomere Biology and Cellular Senescence

Epithalon is the gold-standard peptide for inducing telomerase activity in culture. Researchers use it to study the mechanisms of telomere elongation and the retardation of cellular senescence in human somatic cells. It is utilized to investigate the potential for extending the proliferative lifespan of cells beyond their natural division limits.

Oncology and Tumor Suppression

The peptide is used in oncology research to study its inhibitory effects on spontaneous tumor incidence and specific carcinogenesis models. Studies involve measuring the expression of oncogenes (such as HER-2/neu) and observing tumor progression in colon and breast cancer models.

Lifespan and Aging Models

Epithalon is frequently employed in longevity studies using Drosophila melanogaster and rodent models. Researchers quantify changes in biomarkers of aging, mean lifespan, and the incidence of age-related pathologies to evaluate the peptide’s geroprotective potential.

Reproductive Aging

Recent investigations utilize Epithalon to study post-ovulatory aging. In mouse oocyte models, the peptide is applied to observe its protective effects against oxidative damage and chromosomal abnormalities, providing data on the preservation of gamete quality.

Pathway / Mechanistic Context

The primary mechanism of action for Epithalon involves epigenetic regulation and enzymatic activation.

• Telomerase Activation: Epithalon induces the expression of the catalytic subunit of telomerase, leading to the synthesis of telomeric DNA repeats at the ends of chromosomes.
• Chromatin Stabilization: By maintaining telomere length, the peptide helps prevent chromosome aberrations and genomic instability often associated with aging.
• Antioxidant Regulation: Epithalon modulates the activity of antioxidant enzymes (SOD, peroxidase), enhancing the cell’s resistance to reactive oxygen species (ROS).

Preclinical Research Summary

Published preclinical literature documents investigations of Epithalon across multiple experimental models:

• Telomere Elongation: Studies in human somatic cells demonstrated that Epithalon treatment induced telomerase activity and elongated telomeres, effectively increasing the number of population doublings.
• Tumor Inhibition: Research in transgenic mice showed that Epithalon inhibited the growth of breast tumors and downregulated the expression of the HER-2/neu oncogene. Similarly, it demonstrated an inhibitory effect on colon carcinogenesis in rat models.
• Lifespan Extension: Experiments with Drosophila melanogaster and Swiss-derived SHR mice indicated that Epithalon administration significantly increased mean lifespan and reduced the frequency of spontaneous tumors.

Form & Analytical Testing

This material is produced via robust chemical synthesis and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm molecular weight and sequence identity.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the ≥99% purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Khavinson, V., Bondarev, I., & Butyugov, A. (2003). Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells. Bulletin of Experimental Biology and Medicine, 135, 590-592. https://doi.org/10.1023/A:1025493705728
• Shi-Liang, T. (2007). Retarding the cellular senescence by Epithalon and changes of telomere length and telomerase activity in the retarding process. Journal of Chongqing College of Education.
• Anisimov, V., et al. (2004). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology, 4, 193-202. https://doi.org/10.1023/A:1025114230714
• Khavinson, V., Izmaylov, D., Obukhova, L., & Malinin, V. (2000). Effect of epitalon on the lifespan increase in Drosophila melanogaster. Mechanisms of Ageing and Development, 120, 141-149. https://doi.org/10.1016/S0047-6374(00)00217-7
• Khavinson, V., Bondarev, I., Butyugov, A., & Smirnova, T. (2004). Peptide Promotes Overcoming of the Division Limit in Human Somatic Cell. Bulletin of Experimental Biology and Medicine, 137, 503-506. https://doi.org/10.1023/B:BEBM.0000038164.49947.8c
• Rosenfeld, S., et al. (2002). Effect of Epithalon on the Incidence of Chromosome Aberrations in Senescence-Accelerated Mice. Bulletin of Experimental Biology and Medicine, 133, 274-276. https://doi.org/10.1023/A:1015899003974
• Yue, X., et al. (2022). Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. Aging (Albany NY), 14, 3191 – 3202. https://doi.org/10.18632/aging.204007
• Goncharova, N., Vengerin, A., Khavinson, V., & Lapin, B. (2005). Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology, 40, 51-57. https://doi.org/10.1016/j.exger.2004.10.004
• Khavinson, V., & Malinin, V. (2005). Gerontological Aspects of Genome Peptide Regulation. https://doi.org/10.1159/isbn.978-3-318-01193-7
• Kozina, L., Arutjunyan, A., & Khavinson, V. (2007). Antioxidant properties of geroprotective peptides of the pineal gland. Archives of Gerontology and Geriatrics, 44 Suppl 1, 213-6. https://doi.org/10.1016/J.ARCHGER.2007.01.029
• Anisimov, V., et al. (2002). Epithalon Inhibits Tumor Growth and Expression of HER-2/neu Oncogene in Breast Tumors in Transgenic Mice Characterized by Accelerated Aging. Bulletin of Experimental Biology and Medicine, 133, 167-170. https://doi.org/10.1023/A:1015555023692
• Anisimov, V., Khavinson, V., Popovich, I., & Zabezhinski, M. (2002). Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats. Cancer Letters, 183 1, 1-8. https://doi.org/10.1016/S0304-3835(02)00090-3

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.